Controlled size and morphology of EDTMP-doped hydroxyapatite nanoparticles as model for 153Samarium-EDTMP doping

Abstract

In the original article, three authors' names were mistakenly omitted. The complete list of authors and their affiliations are listed above and below.

Sm:HAp Nanopowders Present Antibacterial Activity against Enterococcus faecalis

“…Their attention has been focused to the field of biomaterials in order to create and develop new and improved materials for tissue engineering [1][2][3]. Among these materials, hydroxyapatite (HAp) is one of the most commonly used for bone implants [4][5][6][7][8][9] or it is a drug release system [4,[10][11][12][13][14][15]. Moreover, it has been shown that it is also a good candidate for the role of adsorbent in column chromatography, in order to separate and purify nucleic acids and proteins [3,16,17].…”

“…Moreover, it has been shown that it is also a good candidate for the role of adsorbent in column chromatography, in order to separate and purify nucleic acids and proteins [3,16,17]. It is possible to use hydroxyapatite for a large number of applications in the biomedical field due to its remarkable properties, such as biocompatibility, bioactivity, and osteoconductivity [4,[18][19][20][21]. In live tissue, HAp is the major mineral component of human bones and teeth [4,22,23].…”

“…It is possible to use hydroxyapatite for a large number of applications in the biomedical field due to its remarkable properties, such as biocompatibility, bioactivity, and osteoconductivity [4,[18][19][20][21]. In live tissue, HAp is the major mineral component of human bones and teeth [4,22,23]. Various factors, such as grain size, morphology, surface area, and microporosity [24][25][26], must be taken into account when developing the biomaterial.…”

“…Among the rare-earth elements, samarium (Sm) is a good candidate for different radiation therapies used for cancer treatments. For more than a decade, 153 Sm isotopes have been used for cancer radiation treatments [4,34,35] which are now administered clinically to patients that have symptomatic bone metastases from different types of cancer, mostly prostatic and breast carcinoma, for pain alleviation [4,[34][35][36][37]. In addition, different new studies have used 153 Sm-hydroxyapatite particles as radiation synovectomy agent in the treatment of chronic synovitis [38][39][40][41], especially knee synovitis [38,39].…”